Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
Cancers|December 30, 2025
Real-World Impact of Metformin on Outcomes in Patients with Deficient DNA Mismatch Repair and Microsatellite Instability (dMMR/MSI) Colorectal Cancer Treated with Immune Checkpoint InhibitorsGarima Gupta, Negar Sadeghipour, Fuat Bicer, et al.Pancreas|July 4, 2019
Induction Therapy in Localized Pancreatic CancerWalid L Shaib, Layal Sayegh, Chao Zhang, et al.Journal of Geriatric Oncology|November 11, 2019
In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomyWalid L Shaib, Katerina Zakka, Farhan N Hoodbhoy, et al.Journal for Immunotherapy of Cancer|October 18, 2023
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancerMehmet Akce, Batoul Farran, Jeffrey M Switchenko, et al.Cancer|November 21, 2018
Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancerWalid L Shaib, Amit Surya Narayan, Jeffrey M Switchenko, et al.Journal of Geriatric Oncology|October 8, 2023
Implementation of the Web-Enabled Cancer & Aging Resilience Evaluation (WeCARE) in an outpatient oncology settingChristian Harmon, Mackenzie Fowler, Smith Giri, et al.Future Oncology (London, England)|November 24, 2025
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancersMasafumi Ikeda, Marcus-Alexander Wörns, Mehmet Akce, et al.NPJ Precision Oncology|February 26, 2026
Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancerIbrahim Halil Sahin, Joanne Xiu, Yasmine Baca, et al.BMC Cancer|August 30, 2019
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapyMehmet Asim Bilen, Julie M Shabto, Dylan J Martini, et al.Cell Reports. Medicine|December 27, 2024
Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquineGanji Purnachandra Nagaraju, Madhu Sudhana Saddala, Jeremy B Foote, et al.Pageof 9